Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lung changes in amiodarone therapy].

L Prayer, P Hübsch, H Frank

    Pneumologie (Stuttgart, Germany)
    |November 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Amiodarone treatment for ventricular arrhythmia can cause lung changes mimicking pulmonary edema. These radiological findings resolved after discontinuing the medication, highlighting amiodarone

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    THE MULTIFACTOR BEHAVIORAL APPROACH TO THE GENETIC-ETIOLOGICAL DIAGNOSIS OF MENTAL RETARDATION.

    Multivariate behavioral research·2016
    Same author

    Corrigendum to: 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases.

    European heart journal·2015
    Same author

    Inhibition training in wolves and dogs.

    Behavioural processes·2014
    Same author

    Haloacetic acids, phytotoxic secondary air pollutants.

    Environmental science and pollution research international·2013
    Same author

    Dioxin '93- 13th international symposium on chlorinated dioxins and related compounds vienna, austria, september 20-24, 1993.

    Environmental science and pollution research international·2013
    Same author

    IMTOX - An interdisciplinary initiative.

    Environmental science and pollution research international·2013
    Same journal

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    [Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    [Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    [Acute lung failure].

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    [The internet as a source of information for patients with sarcoidosis].

    Pneumologie (Stuttgart, Germany)·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pulmonology
    • Pharmacology

    Background:

    • Severe ventricular arrhythmia necessitates treatment with antiarrhythmic drugs.
    • Amiodarone is a commonly prescribed medication for managing complex cardiac arrhythmias.

    Observation:

    • A 59-year-old patient developed pulmonary changes on chest X-ray after two years of amiodarone therapy.
    • The observed opacities were consistent with pulmonary edema but attributed to an adverse drug effect.

    Findings:

    • Pulmonary opacities, resembling lung edema, were identified as a potential adverse effect of amiodarone.
    • Cessation of amiodarone therapy led to the radiological regression of lung changes within one year.

    Implications:

    • Clinicians should consider amiodarone-induced pulmonary toxicity in patients presenting with unexplained pulmonary opacities.

    Related Experiment Videos

  • Monitoring for pulmonary adverse effects is crucial for patients on long-term amiodarone treatment.
  • Early recognition and drug discontinuation can lead to favorable outcomes in amiodarone-induced lung disease.